These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8889080)

  • 41. Noncompliance in schizophrenia.
    Babiker IE
    Psychiatr Dev; 1986; 4(4):329-37. PubMed ID: 2883650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonadherence to antipsychotics: the role of positive attitudes towards positive symptoms.
    Moritz S; Hünsche A; Lincoln TM
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1745-52. PubMed ID: 25444234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Illness self-management for individuals in acute psychiatric care settings in Japan: cross-cultural adaptation of an American program.
    Saito M; Edo K; Yamamoto Y; Niwa S; Liberman RP
    Psychiatr Rehabil J; 2013 Dec; 36(4):272-7. PubMed ID: 24320836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Compliance problems in treatment of schizophrenic patients].
    Barnas C; Hummer M; Fleischhacker WW
    Wien Med Wochenschr; 1998; 148(11-12):281-3. PubMed ID: 9746971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
    Remington G; Kwon J; Collins A; Laporte D; Mann S; Christensen B
    Schizophr Res; 2007 Feb; 90(1-3):229-37. PubMed ID: 17208414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders.
    Duncan JC; Rogers R
    J Forensic Sci; 1998 Nov; 43(6):1133-7. PubMed ID: 9846389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.
    Diaz E; Levine HB; Sullivan MC; Sernyak MJ; Hawkins KA; Cramer JA; Woods SW
    J Psychiatry Neurosci; 2001 Sep; 26(4):325-9. PubMed ID: 11590972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics.
    Kapur S; Ganguli R; Ulrich R; Raghu U
    Schizophr Res; 1991 Dec; 6(1):49-53. PubMed ID: 1686184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical characteristics, health beliefs and compliance with maintenance treatment: a comparison between regular and irregular attenders at a depot clinic.
    Pan PC; Tantam D
    Acta Psychiatr Scand; 1989 Jun; 79(6):564-70. PubMed ID: 2569803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of noncompliance in patients with schizophrenia.
    Perkins DO
    J Clin Psychiatry; 2002 Dec; 63(12):1121-8. PubMed ID: 12523871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 53. [Depot antipsychotics in the year 2011].
    Knegtering H; Oolders H; Ruijsink MA; van der Moolen AE
    Tijdschr Psychiatr; 2011; 53(2):95-105. PubMed ID: 21319066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developing and maintaining adherence to long-term drug-taking regimens.
    Falloon IR
    Schizophr Bull; 1984; 10(3):412-7. PubMed ID: 6147891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Co-enaesthetic schizophrenia. Case studies of illness perception and compliance].
    Schmoll D
    Fortschr Neurol Psychiatr; 1994 Oct; 62(10):372-8. PubMed ID: 8001893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
    Benoit M; Pon J; Zimmermann MA
    Encephale; 2009 Jan; Suppl 3():S87-90. PubMed ID: 19268184
    [No Abstract]   [Full Text] [Related]  

  • 59. Subjective experience and subjective response to neuroleptics in schizophrenia.
    Rossi A; Arduini L; Stratta P; Pallanti S
    Compr Psychiatry; 2000; 41(6):446-9. PubMed ID: 11086150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia.
    Rogers A; Day JC; Williams B; Randall F; Wood P; Healy D; Bentall RP
    Soc Sci Med; 1998 Nov; 47(9):1313-23. PubMed ID: 9783874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.